{
  "meta": {
    "title": "Adrenal_Lesions",
    "url": "https://brainandscalpel.vercel.app/adrenal-lesions-d9dbad58.html",
    "scrapedAt": "2025-11-30T08:48:54.198Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortisol</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolactin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents to the clinic with complaints of fatigue, weakness, and weight loss. On examination, his blood pressure is low, and he shows signs of hyperpigmentation around the gums and palmar creases. Laboratory tests reveal low sodium (hyponatremia), high potassium (hyperkalemia), and low blood glucose levels. Further investigations show reduced levels of cortisol and aldosterone. A CT scan of the abdomen shows small, atrophic adrenal glands. Based on these findings, which of the following hormones is most likely deficient in this patient?</span></p>",
      "unique_key": "DT1295047",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul><li>This patient presents with classic signs of <strong>Addison's disease (primary adrenal insufficiency)</strong>, characterized by reduced cortisol and aldosterone production.</li><li><strong>Cortisol deficiency</strong> causes fatigue, weight loss, hypoglycemia, and weakness.</li><li><strong>Aldosterone deficiency</strong> leads to hyponatremia, hyperkalemia, and hypotension.</li><li>Hyperpigmentation is a hallmark due to <strong>increased ACTH</strong> stimulating melanocytes.</li><li><strong>Epinephrine</strong> is produced by the adrenal medulla and remains unaffected.</li><li><strong>Testosterone</strong> production remains mostly unaffected as gonadal production is more critical than adrenal androgens.</li><li><strong>Prolactin</strong> is a pituitary hormone, unrelated to adrenal insufficiency.</li></ul><p><strong>Key Takeaways:</strong></p><ul><li>Addison&rsquo;s disease results in <strong>low cortisol and aldosterone</strong> with compensatory high ACTH levels causing hyperpigmentation.</li><li>The adrenal medulla remains intact in primary adrenal insufficiency.</li></ul> ",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen </span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">DHT</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">DHEA</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male presents with complaints of fatigue, decreased libido, and loss of muscle mass over the past few months. He reports no significant medical history. On examination, there is decreased body hair, and laboratory tests reveal low serum testosterone levels. Further investigation shows a deficiency of adrenal androgens, but normal cortisol and aldosterone levels.<br>Which of the following adrenal hormones is most likely deficient in this patient?</span></p>",
      "unique_key": "DT1295441",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295441,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul><li><strong>DHEA (Dehydroepiandrosterone)</strong> is produced in the <strong>zona reticularis</strong> of the adrenal cortex and serves as a precursor for the synthesis of <strong>testosterone and estrogen</strong> in peripheral tissues.</li><li><strong>Cortisol</strong> is a glucocorticoid, <strong>aldosterone</strong> is a mineralocorticoid, and <strong>epinephrine</strong> is produced by the adrenal medulla, none of which contribute to sex steroid synthesis.</li></ul><p><strong>Key Takeaways:</strong></p><ul><li>DHEA is the main precursor for <strong>androgens</strong> and <strong>estrogens</strong> synthesized in peripheral tissues.</li></ul> ",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">21-hydroxylase</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxylase</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">17&alpha;-hydroxylase</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">CYP11A1 (side-chain cleavage enzyme)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which enzyme is crucial for the conversion of cholesterol to pregnenolone, the first step in adrenal steroidogenesis?</span></p>",
      "unique_key": "DT1295443",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul><li><strong>CYP11A1</strong>, also known as <strong>side-chain cleavage enzyme</strong>, catalyzes the conversion of <strong>cholesterol to pregnenolone</strong>, which is the precursor to all adrenal steroids. This critical step occurs in the <strong>mitochondria</strong> of adrenal cortex cells.</li></ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109076fb3a2-6117-4cd2-834b-6d85d9c6a9eb.jpg\"><p><strong>Key Takeaways:</strong></p><ul><li>The <strong>side-chain cleavage enzyme (CYP11A1)</strong> initiates the pathway for all adrenal steroids by converting cholesterol to pregnenolone.</li></ul> ",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxylase</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxysteroid dehydrogenase type 1 (HSD11B1)</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">11&beta;-hydroxysteroid dehydrogenase type 2 (HSD11B2)</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">17&beta;-hydroxysteroid dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following enzymes is responsible for converting cortisol into its inactive form, cortisone, in the kidney?</span></p>",
      "unique_key": "DT1295445",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul><li><strong>11&beta;-Hydroxysteroid dehydrogenase type 2 (HSD11B2)</strong> inactivates <strong>cortisol by converting it into cortisone</strong> in the kidney. This protects the <strong>mineralocorticoid receptor</strong> from excessive cortisol activation, allowing aldosterone to function effectively.</li></ul><p><strong>Key Takeaways:</strong></p><ul><li><strong>HSD11B2</strong> is crucial for inactivating cortisol in mineralocorticoid-sensitive tissues, maintaining normal electrolyte balance.</li></ul> ",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">McCune-Albright syndrome</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's disease </span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic ACTH production</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman presents with progressive weight gain, facial rounding, and proximal muscle weakness. Her blood pressure is elevated, and she has noticed thinning of her skin with easy bruising. <br>On examination, she has central obesity and a dorsocervical fat pad (\"buffalo hump\"). Her laboratory results show elevated serum cortisol levels, but her plasma ACTH levels are suppressed. A high-dose dexamethasone suppression test does not suppress cortisol production, and a CT scan reveals a unilateral adrenal mass. Genetic testing confirms a mutation in the GNAS-1 gene.<br>What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295446",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>This patient's presentation, with <strong>elevated cortisol and suppressed ACTH</strong>, points to <strong>ACTH-independent Cushing's syndrome</strong>, as cortisol production is independent of ACTH stimulation.</li>\r\n<li>The presence of an <strong>adrenal mass</strong> suggests an adrenal source of cortisol overproduction.</li>\r\n<li><strong>McCune-Albright syndrome</strong> is caused by activating mutations in the <strong>GNAS-1 gene</strong>, leading to <strong>autonomous adrenal adenomas</strong> and <strong>ACTH-independent Cushing&rsquo;s syndrome</strong>. Other features of McCune-Albright syndrome include <strong>polyostotic fibrous dysplasia</strong>, <strong>caf&eacute;-au-lait spots</strong>, and <strong>precocious puberty</strong>.</li>\r\n<li><strong>Cushing&rsquo;s disease (B)</strong> is an <strong>ACTH-dependent</strong> condition caused by a pituitary adenoma, which is ruled out by the suppressed ACTH.</li>\r\n<li><strong>Ectopic ACTH production (C)</strong> would lead to elevated ACTH levels, which are absent in this case.</li>\r\n<li><strong>Adrenal carcinoma (D)</strong> is another cause of ACTH-independent Cushing's syndrome, but genetic testing confirming <strong>GNAS-1 mutation</strong> points to McCune-Albright syndrome.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109dda2d9c9-1427-40fc-99c0-45829d542d1e.jpg\">\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>McCune-Albright syndrome is associated with <strong>GNAS-1 mutations</strong>, distinct from other endocrine syndromes like MEN 1 or Carney&rsquo;s complex.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-1, D-2</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-4, C-3, D-2</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-2, C-1, D-4</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-3, C-1, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following tests with their corresponding findings/uses:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501096acbddd8-7116-43e1-b49a-f53812c47b04.jpg\"></span></p>",
      "unique_key": "DT1295448",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295448,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>24-hour urinary free cortisol</strong> (A-3) confirms hypercortisolism when levels exceed twice the normal upper limit.</li>\r\n<li><strong>Dexamethasone overnight suppression test</strong> (B-2) lacks cortisol suppression in Cushing&rsquo;s syndrome.</li>\r\n<li><strong>CRH stimulation test</strong> (C-1) increases both ACTH and cortisol in patients with Cushing&rsquo;s disease (pituitary adenoma).</li>\r\n<li><strong>High-dose dexamethasone test</strong> (D-4) distinguishes between Cushing&rsquo;s disease and ectopic ACTH production.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Dexamethasone tests</strong> are key to diagnosing <strong>Cushing's syndrome</strong> and distinguishing between ACTH-dependent and ACTH-independent causes.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">A 24-hour urinary free cortisol more than twice the upper limit of normal is diagnostic of hypercortisolism.</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma ACTH >15 pg/mL indicates ACTH-independent Cushing's syndrome.</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">The dexamethasone overnight suppression test is positive if plasma cortisol >50 nmol/L in the morning.</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral adrenal hyperplasia can cause ACTH-independent Cushing's syndrome.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about Cushing's syndrome diagnosis is incorrect?</span></p>",
      "unique_key": "DT1295449",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>A) is correct:</strong> A 24-hour urinary free cortisol more than twice the normal range is a diagnostic criterion for Cushing&rsquo;s syndrome.</li>\r\n<li><strong>B) is incorrect:</strong> Plasma <strong>ACTH &gt;15 pg/mL</strong> indicates <strong>ACTH-dependent Cushing's syndrome</strong>, not ACTH-independent.</li>\r\n<li><strong>C) is correct:</strong> The dexamethasone overnight test is considered positive if morning plasma cortisol remains <strong>&gt;50 nmol/L</strong>.</li>\r\n<li><strong>D) is correct:</strong> Bilateral adrenal hyperplasia can lead to <strong>ACTH-independent Cushing&rsquo;s syndrome</strong> by overproducing cortisol independently of ACTH stimulation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>ACTH-dependent</strong> vs <strong>ACTH-independent Cushing's</strong> can be distinguished by <strong>plasma ACTH levels</strong>.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic ACTH production</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's disease (pituitary adenoma)</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal adenoma</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old woman presents with central obesity, muscle weakness, purple striae on her abdomen, and hypertension. Laboratory findings show an elevated 24-hour urinary cortisol excretion and a plasma ACTH level of 25 pg/mL. A CRH stimulation test reveals a 45% increase in ACTH and a 25% increase in cortisol levels. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295450",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>This patient presents with signs of <strong>Cushing's syndrome</strong> (central obesity, muscle weakness, striae).</li>\r\n<li>The <strong>elevated ACTH</strong> level (25 pg/mL) points to <strong>ACTH-dependent Cushing's syndrome</strong>.</li>\r\n<li>A <strong>positive CRH stimulation test</strong> (increased ACTH and cortisol) strongly suggests <strong>Cushing&rsquo;s disease</strong> (pituitary adenoma).</li>\r\n<li><strong>Ectopic ACTH production</strong> (A) typically does not respond to the CRH stimulation test.</li>\r\n<li><strong>Adrenal adenomas</strong> (C) and <strong>carcinomas</strong> (D) are usually <strong>ACTH-independent</strong>, with low ACTH levels.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>A <strong>positive CRH stimulation test</strong> is diagnostic for <strong>Cushing&rsquo;s disease</strong>.</li>\r\n<li><strong>Ectopic ACTH syndrome</strong> does not show a rise in ACTH or cortisol in response to CRH stimulation.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal adenoma</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's disease (pituitary adenoma)</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic ACTH production</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary adrenal hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presents with unexplained weight loss, hyperpigmentation of the skin, and weakness. His laboratory tests show an elevated 24-hour urinary cortisol and a plasma ACTH level of 80 pg/mL. A high-dose dexamethasone suppression test reveals no suppression of cortisol levels. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295451",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>The patient presents with signs of <strong>Cushing&rsquo;s syndrome</strong> (elevated cortisol) and <strong>high ACTH levels</strong> (&gt;80 pg/mL), suggesting <strong>ACTH-dependent Cushing's syndrome</strong>.</li>\r\n<li>The <strong>lack of cortisol suppression</strong> on the high-dose dexamethasone test points to <strong>ectopic ACTH production</strong>, commonly caused by tumors such as <strong>small-cell lung cancer</strong>.</li>\r\n<li><strong>Cushing&rsquo;s disease</strong> (B) would typically show suppression of cortisol with high-dose dexamethasone.</li>\r\n<li><strong>Adrenal adenomas</strong> (A) and <strong>primary adrenal hyperplasia</strong> (D) cause <strong>ACTH-independent</strong> Cushing&rsquo;s syndrome, associated with <strong>low ACTH levels</strong>.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010905124540-7fec-48c7-a4cb-94b5668f37a4.jpg\">\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Ectopic ACTH production</strong> is characterized by <strong>high ACTH</strong> and <strong>no suppression</strong> with high-dose dexamethasone.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate bilateral adrenalectomy</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate medical therapy with metyrapone</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy or stereotactic radiosurgery</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase hydrocortisone replacement dose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman with Cushing's disease undergoes selective transsphenoidal surgery to remove a pituitary adenoma. Postoperatively, her cortisol levels remain elevated, and she develops recurrent symptoms six months later. What is the most appropriate next step in management?</span></p>",
      "unique_key": "DT1295453",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Radiotherapy or stereotactic radiosurgery</strong> is often used when there is <strong>recurrent pituitary disease</strong> after surgery, aiming to control tumor growth and reduce cortisol production.</li>\r\n<li><strong>Bilateral adrenalectomy</strong> is reserved for <strong>refractory cases</strong> or when other treatments fail.</li>\r\n<li><strong>Metyrapone</strong> can be used to control cortisol, but <strong>radiotherapy</strong> is preferred for <strong>tumor control</strong> in this scenario.</li>\r\n<li><strong>Increasing hydrocortisone</strong> would not be appropriate if cortisol levels are high.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Radiotherapy</strong> is a key treatment modality for recurrent <strong>Cushing&rsquo;s disease</strong> after unsuccessful surgery.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Biopsy the mass</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat CT imaging in 6 months</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Discharge the patient</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform urine steroid metabolomics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female is found to have a 2.5 cm adrenal mass with no evidence of hormone excess on initial screening. Imaging reveals a mass with 15 HU. What is the next best step in management?</span></p>",
      "unique_key": "DT1295454",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Adrenal Mass Management:</strong></p>\r\n<ol>\r\n<li><strong>Adrenal Mass Detected on Imaging:</strong>\r\n<ul>\r\n<li>Initial Assessment: Determine size, imaging characteristics (HU, shape, contrast washout).</li>\r\n<li>Evaluate for Hormone Excess: Test cortisol, aldosterone, and catecholamines.</li>\r\n</ul></li>\r\n<li><strong>If Mass &le; 4 cm and Non-Functioning, Benign Appearance (HU &le; 20):</strong>\r\n<ul>\r\n<li><strong>Management:</strong> Routine follow-up without immediate intervention (e.g., discharge or imaging in 6-12 months).</li>\r\n</ul></li>\r\n<li><strong>If Suspicious Features or Functionality Detected:</strong>Further evaluation including imaging, potential biopsy, or surgery depending on size and symptoms.</li>\r\n</ol>\r\n<ul>\r\n<li><strong>A) Biopsy the mass:</strong> Biopsy is not indicated for benign-appearing adrenal masses, especially when the imaging characteristics (HU &le; 20) suggest no immediate malignancy risk.</li>\r\n<li><strong>B) Repeat CT imaging in 6 months:</strong> Although follow-up imaging may be considered, discharging the patient with instructions for routine monitoring is appropriate here due to benign features.</li>\r\n<li><strong>C) Discharge the patient and follow up later:</strong> Correct; benign characteristics on imaging (low Hounsfield Units) suggest that the mass is likely a benign adenoma, and immediate intervention is not required.</li>\r\n<li><strong>D) Perform urine steroid metabolomics:</strong> This test is typically reserved for cases where there is a suspicion of malignancy or hormone-producing tumors, not for benign-appearing lesions.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Conn's syndrome</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Liddle's syndrome</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoid-Remediable Aldosteronism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Initially thought to be a rare cause of hypertension, which condition was first described as an aldosterone-producing adrenal adenoma?</span></p>",
      "unique_key": "DT1295455",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295455,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Conn syndrome, also known as <strong>primary hyperaldosteronism</strong>, is a condition in which the adrenal glands produce too much aldosterone, a hormone that regulates <strong>sodium and potassium balance in the body</strong>. Excessive aldosterone leads to an imbalance, causing the body to retain too much sodium and lose potassium, which in turn increases blood pressure.</p>\r\n<ul>\r\n<li><strong>A) Conn&rsquo;s syndrome:</strong> Correct; Conn&rsquo;s syndrome refers to primary aldosteronism caused by an aldosterone-producing adrenal adenoma. Initially considered rare, it is now recognized as a more common cause of secondary hypertension.</li>\r\n<li><strong>B) Liddle&rsquo;s syndrome:</strong> A genetic disorder affecting sodium channels, unrelated to aldosterone-producing adenomas.</li>\r\n<li><strong>C) Cushing&rsquo;s syndrome:</strong> Results from excess cortisol, not aldosterone.</li>\r\n<li><strong>D) Glucocorticoid-Remediable Aldosteronism:</strong> A genetic form of primary aldosteronism distinct from Conn&rsquo;s syndrome, typically responsive to glucocorticoids.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Normotensive individuals</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemic hypertension</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemic hypertension</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal artery stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoid excess is more prevalent in patients with which specific condition?</span></p>",
      "unique_key": "DT1295456",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295456,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Mineralocorticoid excess is a condition where there is an overproduction or excessive action of mineralocorticoids, primarily <strong>aldosterone</strong>, which leads to sodium retention, potassium excretion, and increased blood pressure.</p>\r\n<p><strong>Symptoms</strong> are often related to high blood pressure and low potassium levels, including:</p>\r\n<ul>\r\n<li>Hypertension (often resistant to conventional treatments)</li>\r\n<li>Hypokalemia (low potassium), which can cause:\r\n<ul>\r\n<li>Muscle weakness or cramps</li>\r\n<li>Fatigue</li>\r\n<li>Headaches</li>\r\n<li>Numbness or tingling</li>\r\n</ul>\r\n</li>\r\n<li>Excessive thirst and urination</li>\r\n</ul>\r\n<p><strong>Incorrect Options:</strong></p>\r\n<p><strong>Option A) Normotensive individuals:</strong> Rarely associated with mineralocorticoid excess.</p>\r\n<p><strong>Option B) Hyperkalemic hypertension:</strong> Opposite of what is typically seen in mineralocorticoid excess, as aldosterone usually causes potassium loss.</p>\r\n<p><strong>Option C) Hypokalemic hypertension:</strong> Correct; this condition is a hallmark of mineralocorticoid excess due to aldosterone's effects on sodium retention and potassium excretion.</p>\r\n<p><strong>Option D) Renal artery stenosis:</strong> Causes renovascular hypertension, not primary mineralocorticoid excess.</p>\r\n ",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary aldosteronism</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Liddle's syndrome</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Syndrome of Apparent Mineralocorticoid Excess (SAME)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the most common cause of Mineralocorticoid Excess?</span></p>",
      "unique_key": "DT1295457",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295457,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Causes of Mineralocorticoid Excess</strong></p>\r\n<ol>\r\n<li><strong>Primary Aldosteronism (Conn Syndrome)</strong>: Excessive production of aldosterone by the adrenal glands due to an adrenal adenoma (tumor) or bilateral adrenal hyperplasia.</li>\r\n<li><strong>Secondary Aldosteronism</strong>: Increased aldosterone production in response to conditions that lower blood volume or blood flow, such as:\r\n<ul>\r\n<li><strong>Heart failure</strong></li>\r\n<li><strong>Liver cirrhosis</strong></li>\r\n<li><strong>Kidney disease</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Apparent Mineralocorticoid Excess (AME)</strong>: A genetic condition where the enzyme 11&beta;-hydroxysteroid dehydrogenase type 2 (11&beta;-HSD2) is deficient or dysfunctional, allowing cortisol to act like aldosterone on mineralocorticoid receptors.</li>\r\n<li><strong>Cushing's Syndrome</strong>: Excessive cortisol levels can overwhelm 11&beta;-HSD2 and allow cortisol to activate mineralocorticoid receptors, mimicking aldosterone&rsquo;s effects</li>\r\n</ol>\r\n<p><strong>Option A) Adrenocortical carcinoma:</strong> A rare cause of mineralocorticoid excess, typically presenting with mixed hormone secretion.</p>\r\n<p><strong>Option B) Primary aldosteronism:</strong> Correct; it is the most common cause, often due to an aldosterone-producing adenoma or bilateral adrenal hyperplasia.</p>\r\n<p><strong>Option C) Liddle&rsquo;s syndrome:</strong> A genetic condition that mimics mineralocorticoid excess but without elevated aldosterone levels.</p>\r\n<p><strong>Option D) SAME:</strong> A rare genetic disorder affecting cortisol metabolism, leading to mineralocorticoid effects.</p>\r\n ",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona fasciculata</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona glomerulosa</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona reticularis</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal medulla</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which adrenal zone is responsible for aldosterone production in primary aldosteronism?</span></p>",
      "unique_key": "DT1295459",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295459,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>A) Zona fasciculata:</strong> Produces glucocorticoids like cortisol.</li>\r\n<li><strong>B) Zona glomerulosa:</strong> Correct; this outer layer of the adrenal cortex produces aldosterone, the key mineralocorticoid.</li>\r\n<li><strong>C) Zona reticularis:</strong> Produces androgens, not aldosterone.</li>\r\n<li><strong>D) Adrenal medulla:</strong> Secretes catecholamines (epinephrine and norepinephrine), not aldosterone.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109c0494615-df7e-43e0-afc4-788b24920f44.jpg\">\r\n ",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Unilateral adrenal adenomas</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral micronodular hyperplasia</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital adrenal hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In primary aldosteronism, which condition is more common?</span></p>",
      "unique_key": "DT1295461",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295461,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option A) Unilateral adrenal adenomas:</strong> Common but less prevalent than bilateral hyperplasia.</p>\r\n<p><strong>Option B) Bilateral micronodular hyperplasia:</strong> Correct; this is a common presentation in primary aldosteronism, leading to excessive aldosterone production.</p>\r\n<p><strong>Option C) Adrenocortical carcinoma:</strong> Rare and typically presents with mixed hormone production.</p>\r\n<p><strong>Option D) Congenital adrenal hyperplasia:</strong> A genetic disorder affecting steroidogenesis, unrelated to primary aldosteronism.</p>\r\n ",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona fasciculata cells</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona glomerulosa cells</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona reticularis cells</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal medulla cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Somatic mutations in which cells are common causes of aldosterone-producing adenomas?</span></p>",
      "unique_key": "DT1295464",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295464,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>A) Zona fasciculata cells:</strong> Involved in cortisol production, not aldosterone.</li>\r\n<li><strong>B) Zona glomerulosa cells:</strong> Correct; mutations in these cells drive aldosterone overproduction in aldosterone-producing adenomas.</li>\r\n<li><strong>C) Zona reticularis cells:</strong> Involved in androgen production.</li>\r\n<li><strong>D) Adrenal medulla cells:</strong> Produce catecholamines, not aldosterone.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109c0494615-df7e-43e0-afc4-788b24920f44.jpg\">\r\n ",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary aldosteronism due to bilateral macronodular adrenal hyperplasia</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What can germline mutations lead to in the context of Mineralocorticoid Excess?</span></p>",
      "unique_key": "DT1295465",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295465,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>A) Primary aldosteronism due to bilateral macronodular adrenal hyperplasia:</strong> Correct; germline mutations can cause familial forms of hyperaldosteronism characterized by macronodular growth.</li>\r\n<li><strong>B) Cushing's syndrome:</strong> Caused by cortisol excess, not directly related to mineralocorticoid excess.</li>\r\n<li><strong>C) Pheochromocytoma:</strong> A catecholamine-secreting tumor, unrelated to aldosterone production.</li>\r\n<li><strong>D) Addison&rsquo;s disease:</strong> Characterized by adrenal insufficiency, not mineralocorticoid excess.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Macronodular hyperplasia</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Micronodular hyperplasia</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Unilateral adenoma</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the typical presentation of bilateral adrenal hyperplasia in Mineralocorticoid Excess?</span></p>",
      "unique_key": "DT1295467",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295467,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Micronodular adrenal hyperplasia is a rare condition characterized by the growth of tiny, <strong>benign nodules in the adrenal glands</strong>, leading to excess production of adrenal hormones. The condition typically involves <strong>cortisol overproduction,</strong> which can cause Cushing&rsquo;s syndrome when cortisol levels become too high<strong>.</strong></p>\r\n<p><strong>Option A) Macronodular hyperplasia:</strong> Less common and often associated with genetic forms.</p>\r\n<p><strong>Option B) Micronodular hyperplasia:</strong> Correct; the most common presentation in bilateral adrenal hyperplasia, leading to increased aldosterone production.</p>\r\n<p><strong>Option C) Unilateral adenoma:</strong> Typically seen in cases of Conn&rsquo;s syndrome.</p>\r\n<p><strong>Option D) Carcinoma:</strong> Rare and not typically associated with bilateral hyperplasia.</p>\r\n ",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal adenoma</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma (ACC)</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Liddle's syndrome</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Conn's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which condition should be considered in younger patients with larger adrenal tumors (>2 cm)?</span></p>",
      "unique_key": "DT1295468",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295468,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Adrenocortical cancer (ACC)</strong> is a rare but aggressive cancer that originates in the outer layer (cortex) of the adrenal glands, which are located on top of the kidneys.</p>\r\n<p>The adrenal cortex is responsible for producing hormones like cortisol, aldosterone, and androgens (sex hormones). ACC can cause an overproduction of these hormones, leading to a variety of symptoms.</p>\r\n<p><strong>Option A) Adrenal adenoma:</strong> Common but typically smaller and less aggressive.</p>\r\n<p><strong>Option B) Adrenocortical carcinoma (ACC):</strong> Correct; especially in younger patients with larger tumors, ACC should be suspected due to its aggressive nature.</p>\r\n<p><strong>Option C) Liddle&rsquo;s syndrome:</strong> A genetic condition unrelated to adrenal tumors.</p>\r\n<p><strong>Option D) Conn&rsquo;s syndrome:</strong> Typically presents with smaller aldosterone-producing adenomas.</p>\r\n ",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">CYP11B1 mutation</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">ENaC subunit mutation</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">HSD11B2 mutation</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Renin gene mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What genetic mutation causes Liddle's syndrome?</span></p>",
      "unique_key": "DT1295471",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295471,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Liddle syndrome is a rare genetic disorder that affects the <strong>kidneys' ability to regulate salt and water balance, leading to severe hypertension (high blood pressure) and low potassium levels (hypokalemia</strong>).</p>\r\n<p>It is an <strong>autosomal dominant</strong> condition, meaning it can be inherited from just one affected parent, and is caused by mutations in genes involved in the sodium channels of the kidney tubules.</p>\r\n<p><strong>Symptoms</strong></p>\r\n<ul>\r\n<li><strong>Severe hypertension</strong>: Often resistant to standard blood pressure medications</li>\r\n<li><strong>Hypokalemia</strong>: Low potassium, which can cause:\r\n<ul>\r\n<li>Muscle weakness or cramps</li>\r\n<li>Fatigue</li>\r\n<li>Heart arrhythmias in severe cases</li>\r\n</ul>\r\n</li>\r\n<li><strong>Metabolic alkalosis</strong>: A condition where the blood becomes more alkaline than normal</li>\r\n<li>Increased thirst and urination (related to kidney dysfunction)</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109cfec6e77-a8a4-4b46-91ae-ce9ed87ed80c.jpg\">\r\n<p><strong>Option A) CYP11B1 mutation:</strong> This mutation is linked to congenital adrenal hyperplasia and not to Liddle&rsquo;s syndrome.</p>\r\n<p><strong>Option B) ENaC subunit mutation:</strong> Correct; Liddle&rsquo;s syndrome is caused by mutations in the epithelial sodium channel (ENaC), specifically in the &beta; or &gamma; subunits, leading to constitutive activation of the channel and excessive sodium reabsorption.</p>\r\n<p><strong>Option C) HSD11B2 mutation:</strong> This mutation is associated with apparent mineralocorticoid excess, not Liddle&rsquo;s syndrome.</p>\r\n<p><strong>Option D) Renin gene mutation:</strong> Mutations in the renin gene can affect blood pressure regulation but are not related to Liddle&rsquo;s syndrome.</p>\r\n ",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked recessive</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Sporadic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Liddle's syndrome is characterized by which inheritance pattern?</span></p>",
      "unique_key": "DT1295473",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295473,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Liddle syndrome is a rare genetic disorder that affects the <strong>kidneys' ability to regulate salt and water balance, leading to severe hypertension (high blood pressure) and low potassium levels (hypokalemia</strong>).</p>\n<p>It is an <strong>autosomal dominant</strong> condition, meaning it can be inherited from just one affected parent, and is caused by mutations in genes involved in the sodium channels of the kidney tubules.</p>\n<p><strong>Symptoms</strong></p>\n<ul>\n<li><strong>Severe hypertension</strong>: Often resistant to standard blood pressure medications</li>\n<li><strong>Hypokalemia</strong>: Low potassium, which can cause:\n<ul>\n<li>Muscle weakness or cramps</li>\n<li>Fatigue</li>\n<li>Heart arrhythmias in severe cases</li>\n</ul></li>\n<li><strong>Metabolic alkalosis</strong>: A condition where the blood becomes more alkaline than normal</li>\n<li>Increased thirst and urination (related to kidney dysfunction)</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109cfec6e77-a8a4-4b46-91ae-ce9ed87ed80c.jpg\">\n<ul>\n<li><strong>A) Autosomal recessive:</strong> This inheritance pattern is seen in disorders like congenital adrenal hyperplasia but not in Liddle&rsquo;s syndrome.</li>\n<li><strong>B) Autosomal dominant:</strong> Correct; Liddle&rsquo;s syndrome is inherited in an autosomal dominant manner, where only one mutated copy of the gene is sufficient to cause the disorder.</li>\n<li><strong>C) X-linked recessive:</strong> Not associated with Liddle&rsquo;s syndrome.</li>\n<li><strong>D) Sporadic:</strong> While mutations can occur de novo, Liddle&rsquo;s syndrome is typically inherited in an autosomal dominant fashion.</li>\n</ul>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium retention and sodium excretion</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium depletion and increased sodium retention</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased calcium retention and magnesium excretion</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrogen retention and metabolic acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the main physiological effect of activating the Mineralocorticoid Receptor (MR)?</span></p>",
      "unique_key": "DT1295476",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295476,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Sodium Retention and Potassium Excretion</strong>: Aldosterone acts on the kidneys to promote sodium retention and potassium excretion. This helps to regulate blood pressure and maintain the balance of fluids and electrolytes.</p>\r\n<ul>\r\n<li><strong>A) Potassium retention and sodium excretion:</strong> Incorrect; MR activation leads to sodium retention and potassium depletion.</li>\r\n<li><strong>B) Potassium depletion and increased sodium retention:</strong> Correct; MR activation causes the kidneys to reabsorb sodium while excreting potassium, leading to volume expansion and hypertension.</li>\r\n<li><strong>C) Increased calcium retention and magnesium excretion:</strong> Not a direct effect of MR activation.</li>\r\n<li><strong>D) Hydrogen retention and metabolic acidosis:</strong> MR activation leads to hydrogen excretion, not retention, contributing to metabolic alkalosis.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAYS: Effects of Mineralocorticoid Receptor Activation</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501090f881da4-33f8-4724-bc17-202cfedc95d0.jpg\">\r\n ",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase sodium retention, reducing potassium loss</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease potassium excretion and prevent hypokalemia</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase sodium delivery to distal tubules, worsening hypokalemia</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Have no impact on potassium levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How do thiazide diuretics affect patients with Mineralocorticoid Excess?</span></p>",
      "unique_key": "DT1295477",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295477,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>A) Increase sodium retention, reducing potassium loss:</strong> Incorrect; thiazides increase sodium delivery to distal nephron sites, enhancing potassium loss.</li>\r\n<li><strong>B) Decrease potassium excretion and prevent hypokalemia:</strong> Opposite effect; thiazides worsen potassium excretion.</li>\r\n<li><strong>C) Increase sodium delivery to distal tubules, worsening hypokalemia:</strong> Correct; thiazides enhance sodium delivery to the distal nephron, increasing potassium excretion and worsening hypokalemia in patients with mineralocorticoid excess.</li>\r\n<li><strong>D) Have no impact on potassium levels:</strong> Incorrect; thiazides significantly affect potassium levels by promoting its loss.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAYS: </strong>Sodium Retention and Potassium Excretion: Aldosterone acts on the kidneys to promote sodium retention and potassium excretion. This helps to regulate blood pressure and maintain the balance of fluids and electrolytes<strong>.</strong></p>\r\n ",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased rates of osteoporosis and type 2 diabetes</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased risk of cardiovascular diseases</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased cognitive function and improved bone health</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernatremia and hypocalcemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What additional health impacts are associated with primary aldosteronism?</span></p>",
      "unique_key": "DT1295479",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295479,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>A) Increased rates of osteoporosis and type 2 diabetes:</strong> Correct; primary aldosteronism is linked to decreased bone mineral density and increased risk of type 2 diabetes due to the effects of aldosterone on metabolic pathways.</li>\r\n<li><strong>B) Decreased risk of cardiovascular diseases:</strong> Incorrect; primary aldosteronism increases cardiovascular risk, including hypertension and stroke.</li>\r\n<li><strong>C) Increased cognitive function and improved bone health:</strong> Incorrect; aldosterone excess impairs cognitive function and bone health.</li>\r\n<li><strong>D) Hypernatremia and hypocalcemia:</strong> Not directly associated with primary aldosteronism.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAYS: Health Impacts of Primary Aldosteronism</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501098a6572fb-43a0-47e8-b6cb-3459942f6b47.jpg\">\r\n ",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}